SEC Form 4 · accession 0001209191-18-037306
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger Hawley
Director
Period of report
Jun 11, 2018
Accepted (ET)
Jun 12, 2018 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jun 11, 2018 | P | 140,000 | $1.4527 | A | 140,000 | D | |
| Common stock | holding | — | — | — | 490,411 | I | By The Hawley Family Trust Dated October 22, 2004 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is a weighted average. This transaction was executed in multiple trades at prices ranging from $1.385 to $1.48. The reporting person undertakes to provide full information regarding the number of shares and prices at which the trades were effected upon request to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission.